Cargando…

Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus

No commercial vaccine is yet available against Group A Streptococcus (GAS), major cause of pharyngitis and impetigo, with a high frequency of serious sequelae in low- and middle-income countries. Group A Carbohydrate (GAC), conjugated to an appropriate carrier protein, has been proposed as an attrac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Benedetto, Roberta, Mancini, Francesca, Carducci, Martina, Gasperini, Gianmarco, Moriel, Danilo Gomes, Saul, Allan, Necchi, Francesca, Rappuoli, Rino, Micoli, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696035/ https://www.ncbi.nlm.nih.gov/pubmed/33202815 http://dx.doi.org/10.3390/ijms21228558

Ejemplares similares

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022)

Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes
por: Citiulo, Francesco, et al.
Publicado: (2021)

GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against Shigella flexneri Serotype 6
por: Raso, Maria Michelina, et al.
Publicado: (2020)

Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
por: Micoli, Francesca, et al.
Publicado: (2018)

GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
por: Micoli, Francesca, et al.
Publicado: (2020)

Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals
por: Di Benedetto, Roberta, et al.
Publicado: (2023)

Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens
por: Gasperini, Gianmarco, et al.
Publicado: (2022)

Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models
por: Micoli, Francesca, et al.
Publicado: (2021)

Impact of O-Acetylation on S. flexneri 1b and 2a O-Antigen Immunogenicity in Mice
por: Arato, Vanessa, et al.
Publicado: (2021)

Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens
por: Di Benedetto, Roberta, et al.
Publicado: (2021)

Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)
por: Mancini, Francesca, et al.
Publicado: (2021)

Potential targets for next generation antimicrobial glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2018)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease
por: Lanzilao, Luisa, et al.
Publicado: (2015)

Increasing the High Throughput of a Luminescence-Based Serum Bactericidal Assay (L-SBA)
por: Aruta, Maria Grazia, et al.
Publicado: (2021)

Effect of O-Antigen Chain Length Regulation on the Immunogenicity of Shigella and Salmonella Generalized Modules for Membrane Antigens (GMMA)
por: Gasperini, Gianmarco, et al.
Publicado: (2021)

Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM(197) conjugate vaccine
por: Micoli, Francesca, et al.
Publicado: (2020)

Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis
por: Fiorino, Fabio, et al.
Publicado: (2017)

Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
por: Micoli, Francesca, et al.
Publicado: (2018)

OMV Vaccines and the Role of TLR Agonists in Immune Response
por: Mancini, Francesca, et al.
Publicado: (2020)

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2023)

Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella
por: Mancini, Francesca, et al.
Publicado: (2023)

Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella
por: Goh, Yun Shan, et al.
Publicado: (2015)

Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against Shigella
por: Rossi, Omar, et al.
Publicado: (2020)

A next-generation GMMA-based vaccine candidate to fight shigellosis
por: Rossi, Omar, et al.
Publicado: (2023)

The role of vaccines in combatting antimicrobial resistance
por: Micoli, Francesca, et al.
Publicado: (2021)

Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
por: Micoli, Francesca, et al.
Publicado: (2021)

The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi
por: Arcuri, M., et al.
Publicado: (2017)

Toward a Shigella Vaccine: Opportunities and Challenges to Fight an Antimicrobial-Resistant Pathogen
por: Raso, Maria Michelina, et al.
Publicado: (2023)

Sugar–Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2015)

Characterization of Competitive ELISA and Formulated Alhydrogel Competitive ELISA (FAcE) for Direct Quantification of Active Ingredients in GMMA-Based Vaccines
por: Rossi, Omar, et al.
Publicado: (2020)

GMMA-Based Vaccines: The Known and The Unknown
por: Mancini, Francesca, et al.
Publicado: (2021)

Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines
por: Buonsanti, Cecilia, et al.
Publicado: (2016)

Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023)

Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes
por: McKenna, Sophie, et al.
Publicado: (2020)

Rational design, preparation and characterization of recombinant Ag85B variants and their glycoconjugates with T-cell antigenic activity against Mycobacterium tuberculosis
por: Rinaldi, Francesca, et al.
Publicado: (2018)

Neisseria meningitidis Factor H Binding Protein Surface Exposure on Salmonella Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both Diseases
por: Necchi, Francesca, et al.
Publicado: (2021)

Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat
por: Arato, Vanessa, et al.
Publicado: (2021)

Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
por: Stefanetti, G., et al.
Publicado: (2020)

Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis
por: Rossi, Omar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eqidqogsbdgducovbsubpum39f